Evolution-Resistant Antibodies
Before vaccines were available in the first years of the COVID-19 pandemic, researchers had engineered antibodies that could block SARS-CoV-2, the virus that causes the disease, to prevent infection or reduce the severity of illness. But as the virus evolved, these drugs stopped working. Antibodies work by binding specific sites on the virus. Antibiotic resistance arises when mutation causes those sites to change. Continue reading → Evolution-Resistant Antibodies
Continue reading → Evolution-Resistant Antibodies